Breaking News

Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here

Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Close

Pfizer Inc (PFE)

	Symbol	Exchange	Currency
	PFE	NYSE	USD	Real-time
	PFE	Mexico	MXN	Delayed
	PFE	Stockholm	SEK	Real-time
	PFE	Hamburg	EUR	Delayed
	PFE	TradeGate	EUR	Delayed
	PFE	Frankfurt	EUR	Delayed
	PFE	Xetra	EUR	Delayed
	PFE	Santiago	USD	Delayed
	PFE	Buenos Aires	ARS	Delayed
	PFIZ34	BM&FBovespa	BRL	Delayed
	PFE	Vienna	EUR	Delayed
	PFE-RM	Moscow	RUB	Real-time
	PFE_KZ	KASE	USD	Delayed
	PFE	Colombia	COP	Delayed
	PFE	Lima	USD	Delayed

Add to/Remove from Watchlist Add to Watchlist

50.65 +0.25 +0.50%

19/05 - Closed. Currency in USD ( Disclaimer )

After Hours

50.65

-0.00

-0.00%

19:59:20 - Real-time Data

Type: Equity

Market: United States

ISIN: US7170811035

CUSIP: 717081103

Volume: 19,668,344
Bid/Ask: 50.65 / 50.73
Day's Range: 49.59 - 50.88

News
Analysis & Opinion

PFE News

This page features the latest news about the Pfizer stock.

U.S. CDC backs COVID boosters for children 5 to 11

U.S. CDC backs COVID boosters for children 5 to 11 By Reuters - 1 hour ago 7

By Manas Mishra and Michael Erman (Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended the COVID-19 vaccine booster for children ages 5 to 11 after an advisory...

U.S. to study whether longer Paxlovid course needed to combat reinfections

U.S. to study whether longer Paxlovid course needed to combat reinfections By Reuters - May 18, 2022

By Michael Erman (Reuters) - The U.S. National Institutes of Health is in talks with Pfizer Inc (NYSE:PFE) about studying whether a longer course of the drugmaker's COVID-19 antiviral treatment...

As U.S. COVID-19 cases rise, so does demand for antivirals

As U.S. COVID-19 cases rise, so does demand for antivirals By Reuters - May 17, 2022

By Ahmed Aboulenein WASHINGTON (Reuters) -Rising COVID-19 cases are driving up the use of therapeutics, with Pfizer Inc (NYSE:PFE)'s oral antiviral treatment Paxlovid seeing a 315% jump over the...

U.S. says use of Pfizer’s COVID-19 antiviral up 315%

U.S. says use of Pfizer’s COVID-19 antiviral up 315%

By FXEmpire - May 17, 2022

By Ahmed Aboulenein WASHINGTON (Reuters) -Use of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks, the U.S. Department of Health and Human Services said...

U.S. FDA authorizes Pfizer's COVID booster shot for young children

U.S. FDA authorizes Pfizer's COVID booster shot for young children By Reuters - May 17, 2022

By Manas Mishra and Michael Erman (Reuters) -The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer (NYSE:PFE) and BioNTech's COVID-19 vaccine for children...

Pfizer, BioNTech Rise After FDA Approves Covid Boosters for Children

Pfizer, BioNTech Rise After FDA Approves Covid Boosters for Children By Investing.com - May 17, 2022

By Liz Moyer Investing.com -- Pfizer Inc (NYSE:PFE) shares rose after the Food and Drug Administration approved its Covid-19 booster shot for children aged 5 to 11. Pfizer stock rose 0.6% in...

FDA authorizes Pfizer booster for children ages 5 to 11

FDA authorizes Pfizer booster for children ages 5 to 11

By Fortune - May 17, 2022

Kids in the age group can get a Pfizer booster dose at least five months after their second shot.

U.S. FDA authorizes Pfizer’s COVID booster shot for young children

U.S. FDA authorizes Pfizer’s COVID booster shot for young children

By FXEmpire - May 17, 2022

(Reuters) – The U.S. Food and Drug Administration has authorized the use of a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11, the regulator said on Tuesday.

FDA authorizes Pfizer Covid booster dose for kids ages 5 to 11 years old

FDA authorizes Pfizer Covid booster dose for kids ages 5 to 11 years old

By CNBC - May 17, 2022

FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT

FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT By Reuters - May 16, 2022 3

(Reuters) -U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech's COVID-19 vaccine for children aged 5 to 11 as soon as Tuesday, the New York Times reported on Monday,...

1 2 3 4 5 6 7 8 9 10

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

PFE Comments

Write your thoughts about Pfizer Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

peter pan 15 hours ago

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

If you want to short a stock without the hassle, I believe Pfizer is the best bet.

1 0

peter pan May 17, 2022 7:01AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

It was too late for Pfizer to authorize booster shots for children ages 5 to 11. Many children are infected every day.

1 0

peter pan May 15, 2022 11:18AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

MERCK continues to rise, but Pfizer falls. That's why Buffett chooses Merck.

1 0

peter pan May 12, 2022 5:31PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Pfizer is a dead cat bounce.

2 0

bhavin dave May 06, 2022 3:47PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Pfizer seems attractively positioned technically for a bounce and might try to fill gaps.

2 3

JayShee May 04, 2022 2:19PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Pfizer's forward earnings should decline dramatically as there is less of a need for their vaccine and/or their therapeutic drug. 1Q was a "transition" to much lower earnings.

2 3

peter pan May 04, 2022 8:50AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

why Moderna goes up so quick, but Pfizer can't. I think the insiders manipulate the stock price.

4 7

Apple Jack May 04, 2022 8:50AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

just stop

2 0

Rafael Jimenez May 04, 2022 4:07AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

solid good company

4 5

peter pan May 03, 2022 5:26PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

what a dead cat bouncing.

4 5

We Fi May 03, 2022 4:00PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

3,6 % deaths it not enough<

2 2

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="237934029">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="237934029" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="237934029">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="237934029">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="224680391">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="224680391" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="224680391">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="224680391">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	31,400.2	+147.1	+0.47%
	US 500	3,924.4	+23.6	+0.61%
	Dow Jones	31,253.13	-236.94	-0.75%
	S&P 500	3,900.79	-22.89	-0.58%
	Nasdaq	11,388.50	-29.66	-0.26%
	S&P 500 VIX	29.35	0.00	0.00%
	Dollar Index	103.045	+0.294	+0.29%

	Crude Oil WTI	108.52	-1.37	-1.25%
	Brent Oil	110.98	-1.06	-0.95%
	Natural Gas	8.056	-0.041	-0.51%
	Gold	1,839.38	-1.82	-0.10%
	Silver	21.840	-0.068	-0.31%
	Copper	4.2635	-0.0130	-0.30%
	US Soybeans	1,689.88	-0.87	-0.05%

	SPDR S&P 500	389.46	-2.40	-0.61%
	iShares Russell 2000	176.53	+0.29	+0.16%
	Invesco QQQ Trust	289.58	-1.56	-0.54%
	Direxion Daily Junior Gold Miners Bull 2X Shares	52.47	+6.15	+13.28%
	iShares Silver	20.27	+0.54	+2.74%
	ProShares Ultra VIX Short-Term Futures	15.98	-1.67	-9.46%
	ProShares UltraPro QQQ	27.58	-0.57	-2.02%

	Apple	137.35	-3.47	-2.46%
	Alphabet A	2,207.68	-30.31	-1.35%
	Tesla	709.42	-0.39	-0.05%
	Amazon.com	2,146.38	+4.13	+0.19%
	Netflix	183.48	+6.29	+3.55%
	Meta Platforms	191.29	-0.95	-0.49%
	Bank of America	34.45	-0.43	-1.23%

Recent Quotes

	Name	Price	Chg.	Chg. %
	PFE	50.65	+0.25	+0.50%

	Name	Last	Chg. %	Vol.
	AMD	96.67	+0.41%	141.06M
	AAPL	137.35	-2.46%	134.70M
	NVDA	171.24	+1.10%	61.80M
	MSFT	253.14	-0.37%	32.29M
	TSLA	709.42	-0.05%	29.83M
	FB	191.29	-0.49%	24.27M
	AMZN	2,146.38	+0.19%	4.38M

	Name	Last	Chg. %	Vol.
	LCID	19.27	+11.00%	39.45M
	SNPS	300.52	+10.25%	2.36M
	DDOG	96.53	+9.60%	8.12M
	PDD	42.05	+8.97%	15.11M
	TEAM	174.75	+7.55%	3.06M
	DOCU	78.18	+7.45%	5.30M
	ZM	90.94	+7.38%	4.69M

	Name	Last	Chg. %	Vol.
	UA	8.18	-15.76%	27.76M
	CSCO	41.72	-13.73%	96.56M
	UAA	9.28	-11.87%	25.58M
	BBWI	40.03	-6.78%	18.90M
	PM	100.50	-5.35%	9.23M
	CLX	138.15	-5.27%	2.35M
	TGT	153.43	-5.06%	23.22M